Tekla Healthcare Valuation

XHQHX Fund  USD 18.87  0.27  1.45%   
Based on Macroaxis valuation methodology, the fund is fairly valued. Tekla Healthcare Inv has a current Real Value of $18.94 per share. The regular price of the fund is $18.87. Our model measures the value of Tekla Healthcare Inv from inspecting the fund technical indicators and probability of bankruptcy. In general, investors recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will draw towards each other.

Tekla Healthcare Total Value Analysis

Tekla Healthcare Investors is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Tekla Healthcare fundamentals before making investing decisions based on enterprise value of the company

Tekla Healthcare Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Tekla suggests not a very effective usage of assets in March.

About Tekla Healthcare Valuation

Our relative valuation model uses a comparative analysis of Tekla Healthcare. We calculate exposure to Tekla Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tekla Healthcare's related companies.

Other Information on Investing in Tekla Mutual Fund

Tekla Healthcare financial ratios help investors to determine whether Tekla Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Healthcare security.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios